Clinical Trials Logo
  1. Home
  2. Cancer of Liver
  3. NCT03766776

Anlotinib in the Treatment of Advanced Hepatocellular Carcinoma (HCC) — ATAHC  

Cancer of Liver Clinical Trial

Official title:
Anlotinib Hydrochloride Capsules in the Treatment of Advanced Hepatocellular Carcinoma (HCC) Open, Single Arm, Exploratory Clinical Trial.

Clinical Trial Summary

This is a prospective, one-arm, exploratory clinical study to observe and evaluate the efficacy and safety of Anlotinib hydrochloride capsules in patients with advanced liver cancer.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT03766776
Study type Interventional
Source The First Affiliated Hospital with Nanjing Medical University
Contact Yongqian Shu, PhD
Phone 0086-13813804568
Email shuyongqian@csco.org.cn
Status Not yet recruiting
Phase N/A
Start date December 31, 2018
Completion date December 31, 2020
View Details
See also
  Status Clinical Trial Phase
Completed NCT01627808 - Fluid Optimization in Liver Surgery N/A
Withdrawn NCT05109052 - Trial of PXS-5505 Combined With First Line Atezolizumab Plus Bevacizumab For Treating Patients With Unresectable Hepatocellular Carcinoma Phase 1/Phase 2
Recruiting NCT05179824 - Tempus Priority Study: A Pan-tumor Observational Study
Recruiting NCT03896958 - The PIONEER Initiative: Precision Insights On N-of-1 Ex Vivo Effectiveness Research Based on Individual Tumor Ownership (Precision Oncology)
Completed NCT05030090 - Integrative Nutrition Care Plan for the Patient With Liver and Colorectal Cancer N/A
Terminated NCT00669136 - Immunization With AFP + GM CSF Plasmid Prime and AFP Adenoviral Vector Boost in Patients With Hepatocellular Carcinoma Phase 1
Recruiting NCT04258813 - Onco-primary Care Networking to Support TEAM-based Care N/A
Completed NCT03299036 - Drug-loadable（T-ACE Beads）for Hepatoma Embolization Therapy N/A
Recruiting NCT03323996 - Impact of a Training in Therapeutic Education on the Relation Between Care Givers and Their Patients N/A
Completed NCT02044224 - Effects of Dexmedetomidine During IRE Procedures for Solid Tumours Phase 4
Not yet recruiting NCT03607643 - A Study of the Efficacy of Cannabidiol in Patients With Multiple Myeloma, Glioblastoma Multiforme, and GI Malignancies Phase 1/Phase 2
Completed NCT05643833 - Impact of Gender on the Outcome of Liver Transplantation for Hepatocellular Carcinoma
Recruiting NCT03452774 - SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Completed NCT02016391 - Effects of Dexmedetomidine During Radiofrequency Ablation of Abdominal Tumours Phase 4
Recruiting NCT00730860 - Treatment of Hepatocellular Carcinoma With Radiofrequency Ablation (RFA) Associated With Postoperative TACE N/A
Terminated NCT00216437 - Dose Escalation Study Combining Oral Capecitabine (Xeloda) and Radiotherapy for Patients With Unresectable Liver or Cholangiocarcinoma Phase 1
Completed NCT04172714 - Low-dose Y90 Treatment Planning for HCC N/A
Active, not recruiting NCT03347162 - Muscle Dysfunction in Gastrointestinal or Hepatobiliary Cancer
Completed NCT05907772 - Incorporation of Protein Induced by Vitamin K Absence or Antagonist-II Into Transplant Criteria Expands Beneficiaries of Liver Transplantation for Hepatocellular Carcinoma
Recruiting NCT04348838 - Prospective Cohort of Patients With Hepatocellular Carcinoma in France